Puretech Health (LON:PRTC)‘s stock had its “buy” rating reiterated by equities research analysts at Peel Hunt in a research report issued to clients and investors on Tuesday. They presently have a GBX 313 ($4.32) price target on the stock. Peel Hunt’s price objective suggests a potential upside of 87.43% from the stock’s previous close.
A number of other equities research analysts have also weighed in on the stock. Numis Securities restated a “buy” rating and issued a GBX 259 ($3.58) price objective on shares of Puretech Health in a report on Tuesday. Liberum Capital restated a “buy” rating and issued a GBX 248 ($3.43) price objective on shares of Puretech Health in a report on Friday, January 26th. N+1 Singer restated a “buy” rating on shares of Puretech Health in a report on Thursday, November 30th. Finally, Jefferies Group restated a “buy” rating on shares of Puretech Health in a report on Friday, November 17th. Five research analysts have rated the stock with a buy rating, The company presently has a consensus rating of “Buy” and a consensus target price of GBX 260.20 ($3.59).
Shares of Puretech Health (PRTC) opened at GBX 167 ($2.31) on Tuesday. Puretech Health has a fifty-two week low of GBX 110 ($1.52) and a fifty-two week high of GBX 183.50 ($2.54). The firm has a market cap of $387.01 and a price-to-earnings ratio of -927.78.
COPYRIGHT VIOLATION WARNING: This story was first published by Stock Observer and is the property of of Stock Observer. If you are accessing this story on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this story can be accessed at https://www.thestockobserver.com/2018/02/20/puretech-health-prtc-given-buy-rating-at-peel-hunt.html.
Puretech Health Company Profile
PureTech Health plc is a cross-disciplinary healthcare company. The Company operates through two segments: growth stage businesses and project phase businesses. Businesses in the growth stage businesses segment are those whose activities focus on developing products to solve healthcare problems in varied markets.
Receive News & Ratings for Puretech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Puretech Health and related companies with MarketBeat.com's FREE daily email newsletter.